Lifecore Biomedical, Inc. (LFCR)
6.38
-0.02
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:08
Lifecore Biomedical Shareholders Equity (Quarterly) : -22.28M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -22.28M |
| June 30, 2026 | 16.09M |
| March 31, 2026 | 20.78M |
| May 31, 2025 | 47.43M |
| February 28, 2025 | 47.43M |
| November 30, 2024 | 59.76M |
| August 31, 2024 | 39.50M |
| May 31, 2024 | 53.90M |
| February 29, 2024 | 59.43M |
| November 30, 2023 | 42.34M |
| August 31, 2023 | 26.55M |
| May 31, 2023 | 35.09M |
| February 28, 2023 | 72.72M |
| November 30, 2022 | 74.17M |
| August 31, 2022 | 80.36M |
| May 31, 2022 | 87.82M |
| February 28, 2022 | 144.07M |
| November 30, 2021 | 156.20M |
| August 31, 2021 | 193.86M |
| May 31, 2021 | 202.78M |
| February 28, 2021 | 204.62M |
| November 30, 2020 | 208.94M |
| August 31, 2020 | 221.16M |
| May 31, 2020 | 231.04M |
| February 29, 2020 | 247.67M |
| Date | Value |
|---|---|
| November 30, 2019 | 259.08M |
| August 31, 2019 | 264.95M |
| May 31, 2019 | 270.14M |
| February 28, 2019 | 270.06M |
| November 30, 2018 | 253.57M |
| August 31, 2018 | 253.38M |
| May 31, 2018 | 252.56M |
| February 28, 2018 | 248.63M |
| November 30, 2017 | 231.19M |
| August 31, 2017 | 229.56M |
| May 31, 2017 | 226.61M |
| February 28, 2017 | 222.61M |
| November 30, 2016 | 218.01M |
| August 31, 2016 | 215.30M |
| May 31, 2016 | 210.73M |
| February 29, 2016 | 205.06M |
| November 30, 2015 | 225.15M |
| August 31, 2015 | 222.30M |
| May 31, 2015 | 218.43M |
| February 28, 2015 | 213.88M |
| November 30, 2014 | 209.52M |
| August 31, 2014 | 205.77M |
| May 31, 2014 | 203.07M |
| February 28, 2014 | 198.02M |
| November 30, 2013 | 188.67M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.363B |
| Bio-Rad Laboratories, Inc. | -- |
| Bruker Corp. | 2.306B |
| Azenta, Inc. | 1.510B |
| Danaher Corp. | 53.62B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 228.30M |
| Total Liabilities (Quarterly) | 250.58M |
| Debt to Equity Ratio | -7.280 |
| Current Ratio | 3.842 |
| Net Debt Paydown Yield | -2.41% |